
Ono Pharmaceutical Co. Ltd.
OPHLY | OTC
$5.33
+$0.18 (+3.50%)
Sep 22, 2026, 11:12 AM ET · Market open
TTM Period Ending | Q1 2027 Jun 29, 2026 | Q4 2026 Mar 30, 2026 | Q3 2026 Dec 30, 2025 | Q2 2026 Sep 29, 2025 | Q1 2026 Jun 29, 2025 | Q4 2025 Mar 30, 2025 | Q3 2025 Dec 30, 2024 | Q2 2025 Sep 29, 2024 | Q1 2025 Jun 29, 2024 | Q4 2024 Mar 30, 2024 | Q3 2024 Dec 30, 2023 | Q2 2024 Sep 29, 2023 | Q1 2024 Jun 29, 2023 | Q4 2023 Mar 30, 2023 | Q3 2023 Dec 30, 2022 | Q2 2023 Sep 29, 2022 | Q1 2023 Jun 29, 2022 | Q4 2022 Mar 30, 2022 | Q3 2022 Dec 30, 2021 | Q2 2022 Sep 29, 2021 | Q1 2022 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 512.91B | 522.75B | 514.13B | 505.93B | 496.73B | 486.87B | 487.33B | 484.3B | 500.33B | 502.67B | 498.07B | 489.2B | 460.48B | 447.19B | 428.95B | 403.99B | 380.72B | 361.36B | 345.78B | 332.89B | 321.73B |
Cost of Revenue | 135.64B | 143.6B | 155.17B | 163.66B | 155.29B | 147.95B | 134.38B | 119.24B | 126.63B | 127.13B | 121.74B | 121.12B | 113.3B | 110.06B | 106.66B | 101.66B | 97.65B | 93.51B | 90.06B | 89.38B | 87.81B |
Gross Profit | 377.27B | 379.16B | 358.96B | 342.27B | 341.44B | 338.92B | 352.95B | 365.06B | 373.71B | 375.55B | 376.33B | 368.08B | 347.19B | 337.13B | 322.29B | 302.33B | 283.07B | 267.85B | 255.73B | 243.51B | 233.93B |
Operating Income | 113.17B | 103.58B | 79.93B | 56.16B | 51.41B | 60.1B | 86.42B | 119.13B | 149.28B | 159.94B | 164B | 158.73B | 145.15B | 141.96B | 143.62B | 125.29B | 111.57B | 103.2B | 98.31B | 104.1B | 101.08B |
Interest Income | 3.97B | 3.23B | 2.76B | 3.87B | 3.19B | 5.23B | 6.01B | 4.99B | 6.24B | 4.82B | 4.1B | 3.77B | 2.59B | 2.48B | 2.58B | 2.51B | 2.55B | 2.71B | 2.64B | 2.72B | 2.73B |
Pretax Income | 102.91B | 93.9B | 77.86B | 57.38B | 48.67B | 59.33B | 88.48B | 119.08B | 154.67B | 163.74B | 166.45B | 161.81B | 146.87B | 143.53B | 145.06B | 126.81B | 113.26B | 105.02B | 100.58B | 106.45B | 103.39B |
Net Income | 77.58B | 70.78B | 63.4B | 48.97B | 42.93B | 50.05B | 74.03B | 95.13B | 120.95B | 127.98B | 127.61B | 124.88B | 115.06B | 112.72B | 111.56B | 96.57B | 85.92B | 80.52B | 73.56B | 81.87B | 78B |
Selling & General & Admin | 118.48B | 125.35B | 125.93B | 128.94B | 128.87B | 125.67B | 117.83B | 108.21B | 101.79B | 97.39B | 93.79B | 91.3B | 88.4B | 86.64B | 82.78B | 79.41B | 76.89B | 74.12B | 75.89B | 74.46B | 71.37B |
Research & Development | 145.61B | 149.03B | 148.56B | 152.69B | 157.26B | 149.87B | 142.75B | 131.62B | 116.45B | 112.17B | 105.86B | 105.08B | 100.51B | 95.35B | 92.39B | 82.96B | 80.05B | 75.88B | 68B | 69.2B | 65.29B |
Other Expenses | 159.78 | 1.19B | 4.54B | 4.47B | 3.9B | 3.28B | 2.81B | 2.96B | 3.05B | 2.91B | 9.84B | 10.13B | 10.28B | 10.33B | 562M | 11.73B | 11.63B | 11.72B | 10.91B | -6.87B | -6.43B |
Operating Expenses | 264.09B | 275.58B | 279.03B | 286.11B | 290.03B | 278.82B | 263.4B | 242.79B | 221.29B | 212.47B | 212.33B | 209.35B | 202.04B | 195.16B | 178.67B | 177.03B | 171.51B | 164.65B | 157.42B | 139.41B | 132.85B |
Interest Expense | 3.61B | 2.82B | 3.49B | 3.08B | 5.7B | 5.77B | 3.94B | 5.05B | 1.2B | 1.37B | 1.66B | 695M | 874M | 912M | 1.14B | 999M | 858M | 882M | 367M | 367.06M | 418.06M |
Selling & Marketing Expenses | n/a | n/a | 30.65B | 30.65B | 30.65B | 30.65B | 24.02B | 24.02B | 24.02B | 24.02B | 17.84B | 17.84B | 17.84B | 17.84B | 11.5B | 11.5B | 11.5B | 11.5B | 6.9B | 6.9B | 6.9B |
Cost & Expenses | 399.73B | 419.17B | 434.2B | 449.76B | 445.33B | 426.77B | 397.77B | 362.02B | 347.91B | 339.6B | 334.07B | 330.47B | 315.33B | 305.22B | 285.33B | 278.69B | 269.15B | 258.17B | 247.47B | 228.79B | 220.65B |
Income Tax Expense | 25.22B | 23.06B | 14.44B | 8.49B | 5.71B | 9.16B | 14.52B | 23.91B | 33.61B | 35.69B | 38.75B | 36.82B | 31.67B | 30.62B | 33.21B | 30.02B | 27.16B | 24.34B | 26.95B | 24.5B | 25.32B |
Shares Outstanding (Basic) | 1.41B | 1.41B | 1.41B | 1.41B | 1.41B | 1.4B | 1.41B | 1.41B | 1.41B | 4.3B | 4.28B | 4.36B | 4.4B | 4.4B | 4.4B | 4.4B | 4.39B | 4.41B | 4.48B | 4.49B | 4.49B |
Shares Outstanding (Diluted) | 1.41B | 1.45B | 1.41B | 1.41B | 1.41B | 1.41B | 1.41B | 1.41B | 1.41B | 4.3B | 4.28B | 4.36B | 4.4B | 4.4B | 4.4B | 4.4B | 4.4B | 4.41B | 4.48B | 4.49B | 4.49B |
EPS (Basic) | 55.20 | 49.98 | 44.74 | 34.51 | 30.45 | 35.49 | 40.22 | 54.86 | 52.71 | 42.37 | 53.94 | 36.27 | 33.95 | 33.41 | 25.37 | 21.88 | 19.35 | 18 | 16.39 | 18.23 | 17.37 |
EPS (Diluted) | 55.18 | 49.95 | 44.72 | 34.47 | 30.41 | 35.47 | 52.63 | 67.27 | 65.13 | 54.78 | 53.92 | 36.25 | 33.93 | 33.40 | 25.37 | 21.88 | 19.34 | 17.99 | 16.38 | 18.22 | 17.36 |
EBITDA | 151.93B | 142.47B | 114.26B | 90.25B | 79.3B | 83.13B | 109.3B | 137.19B | 168.88B | 180.96B | 184.52B | 179.23B | 164.17B | 160.64B | 162.53B | 144.29B | 130.63B | 122.4B | 117.11B | 123.74B | 120.26B |
EBIT | 113.8B | 104.21B | 77.05B | 53.64B | 47.54B | 56.24B | 86.42B | 120.65B | 152.4B | 164.33B | 168.1B | 162.5B | 147.74B | 144.44B | 146.2B | 126.69B | 113B | 104.78B | 99.82B | 106.81B | 103.8B |
Depreciation & Amortization | 38.12B | 38.26B | 37.21B | 36.61B | 31.75B | 26.89B | 22.88B | 18.05B | 17.99B | 18.14B | 17.93B | 17.91B | 17.68B | 17.45B | 17.59B | 17.66B | 17.74B | 17.72B | 17.09B | 16.74B | 16.29B |
Add to Watchlist
Select watchlists to add or remove OPHLY